The Latest Headlines at American Banking and Market News
Revolution Medicines’ (RVMD) “Buy” Rating Reaffirmed at HC Wainwright
Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a note issued to investors on Monday, Benzinga reports. They currently have a $44.00 price target... More of this article »
Everbridge (NASDAQ:EVBG) Receives Hold Rating from Needham & Company LLC
Everbridge (NASDAQ:EVBG – Get Free Report)‘s stock had its “hold” rating restated by stock analysts at Needham & Company LLC in a note issued to investors on Monday, Benzinga reports. Other equities research... More of this article »
SoundHound AI (NASDAQ:SOUN) Stock Rating Reaffirmed by HC Wainwright
SoundHound AI (NASDAQ:SOUN – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued to investors on Monday, Benzinga reports. They presently... More of this article »
Akero Therapeutics (NASDAQ:AKRO) Receives Buy Rating from HC Wainwright
Akero Therapeutics (NASDAQ:AKRO – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research note issued to investors on Monday, Benzinga reports. They currently... More of this article »
Britvic (LON:BVIC) Sets New 1-Year High After Dividend Announcement
Britvic plc (LON:BVIC – Get Free Report)’s stock price reached a new 52-week high during trading on Wednesday following a dividend announcement from the company. The company traded as high as GBX 1,009 ($12.67) and last... More of this article »
Immunocore (NASDAQ:IMCR) Given New $88.00 Price Target at Mizuho
Immunocore (NASDAQ:IMCR – Get Free Report) had its target price lowered by equities researchers at Mizuho from $90.00 to $88.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has a “buy”... More of this article »
Coherus BioSciences (NASDAQ:CHRS) Given New $7.00 Price Target at Truist Financial
Coherus BioSciences (NASDAQ:CHRS – Get Free Report) had its price objective lowered by research analysts at Truist Financial from $8.00 to $7.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently... More of this article »
Provident Bancorp (NASDAQ:PVBC) Given “Equal Weight” Rating at Stephens
Provident Bancorp (NASDAQ:PVBC – Get Free Report)‘s stock had its “equal weight” rating reissued by equities research analysts at Stephens in a report released on Monday, Benzinga reports. They presently have... More of this article »
EQT (NYSE:EQT) Price Target Raised to $47.00 at BMO Capital Markets
EQT (NYSE:EQT – Get Free Report) had its price objective raised by research analysts at BMO Capital Markets from $40.00 to $47.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has an “outperform”... More of this article »
CareDx (NASDAQ:CDNA) Price Target Raised to $18.00 at Stephens
CareDx (NASDAQ:CDNA – Get Free Report) had its target price increased by analysts at Stephens from $15.00 to $18.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has an “overweight”... More of this article »
i3 Verticals (NASDAQ:IIIV) Price Target Cut to $24.00 by Analysts at BMO Capital Markets
i3 Verticals (NASDAQ:IIIV – Get Free Report) had its target price cut by research analysts at BMO Capital Markets from $25.00 to $24.00 in a report released on Monday, Benzinga reports. The brokerage currently has a “market... More of this article »
Stephens Reaffirms Equal Weight Rating for LINKBANCORP (NASDAQ:LNKB)
LINKBANCORP (NASDAQ:LNKB – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by research analysts at Stephens in a research report issued on Monday, Benzinga reports. They currently have a $7.50... More of this article »
Truist Financial Boosts Blue Owl Capital (NYSE:OBDC) Price Target to $18.00
Blue Owl Capital (NYSE:OBDC – Get Free Report) had its target price hoisted by analysts at Truist Financial from $16.00 to $18.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage... More of this article »